Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-782-7 | CAS number: 133937-72-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The mutagenic and clastogenic potential of the test item was investigated in two in vitro gene mutation assays and one chromosome aberration test under GLP and Guideline conform conditions. Based on the results, the test item was neither mutagenic in bacterial cells nor in mammalian cells. Furthermore, the test item did not exhibit a clastogenic potential in mammalian cells.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Apr 22 - Nov 04, 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Principles of method if other than guideline:
- none
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Lot No. E631441
- Expiration date of the lot/batch: 1992-12-20
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: stable
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: soluble in acetone
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: no reactivity
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: no
- Preliminary purification step (if any): no
- Final dilution of a dissolved solid, stock liquid or gel: solution
- Final preparation of a solid: dissolved in acetone - Target gene:
- HIS operon (S. thyphimurium)
TRY operon (E. coli) - Species / strain / cell type:
- S. typhimurium TA 1535
- Details on mammalian cell type (if applicable):
- his G 46, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 1537
- Details on mammalian cell type (if applicable):
- his C 3076, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 98
- Details on mammalian cell type (if applicable):
- his D 3052, uvrB, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 100
- Details on mammalian cell type (if applicable):
- his G 46, uvrB, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- E. coli WP2
- Details on mammalian cell type (if applicable):
- trp C 3076, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the tryptophan operon
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- The WP2 uvrA-strain not only possesses the tryptophan mutation, but also lacks excision repair (uvrA), so that it is more readily mutated by agents such as UV.
- Additional strain / cell type characteristics:
- other: mutations in the tryptophan operon
- Species / strain / cell type:
- S. typhimurium TA 1538
- Details on mammalian cell type (if applicable):
- his D 3052 mutation
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver homogenate (S9 mix) with standard co-factors with metabolic activation (Aroclor)
- Test concentrations with justification for top dose:
- The test material concentrations were used selected according to the EC and OECD guidelines for this test system and the requirements of the Labor Ministry of Japan: 50-1000 µg/plate have been used in the 1st and 2nd series respectively. Precipitation of the test material accured at concentrations larger or equal to 1000 µg/plate.
- Vehicle / solvent:
- Acetone
- Positive controls:
- yes
- Positive control substance:
- cumene hydroperoxide
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- with S9
- Positive controls:
- yes
- Positive control substance:
- other: daunomycine
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- with S9
- Details on test system and experimental conditions:
- The assessment of test material-induced effects is dependent on the number of spontaneous revertants of each bacterial strain (solvent controls) and the increase in the number of revertants at the test material concentration which shows the highest number of colonies.
The following criteria, based upon the historical controls of the laboratory and statistical considerations, are established:
-----------------------------------------------------------------------------------------
Mean Number of Colonies Maximal Mean Number of Colonies over the Actual
(Solvent Control) Solvent Control
(Test Material)
-----------------------------------------------------------------------------------------
<=10 <=9 >=30
<=30 <=19 >=40
<=80 <=29 >=80
<=200 <=49 >=120
<=500 <=79 >=200
Assessment No increase Clear increase
-----------------------------------------------------------------------------------------
All further results, ranging between "no" and "clear", are assessed as "weak in-creases".
Interpretations:
A test material is defined as non-mutagenic in this assay if "no" or "weak increases" occur in the first and second series of the main experiment.
("Weak increases" randomly occur due to experimental variation.)
A test material is defined as mutagenic in this assay if:
- a dose-related (over at least two test material concentrations) increase in the number of revertants is induced, the maximal effect is a "clear increase", and the effects are reproduced at similar concentration levels in the same test system;
- "clear increases" occur at least at one test material concentration, higher concentrations show strong precipitation or cytotoxicity, and the effects are reproduced at the same concentration level in the same test system.
In all further cases, a third test series with the bacterial strain in question should be performed.
If the criteria for a positive test result are not fulfilled in at least two out of the three series, the test material is defined as being non-mutagenic in this test system. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Precipitation occured at concentrations higher or equal to 1000 µg/plate. Toxicity to bacteria was not observed.
- Conclusions:
- With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
- Executive summary:
This study was performed according to GLP and the methods applied are fully compliant with OECD TG 471.
With and without addition of S9 mix as the external metabolizing system, the test material was not mutagenic under the experimental conditions described.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Nov 10, 2000 - Feb 01, 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- Principles of method if other than guideline:
- none
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- mammalian cell line, other: CHL/IU
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Nine hundreds milliliter of MEM was supplemented with 100 mL of heat-inactivated (56C, 30 min) calf serum (GIBCO BRL, lot no.42100611).
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix (induction using PB + BNP)
- Test concentrations with justification for top dose:
- -S9 mix: 920, 1840, 3680 µg / mL
+S9 mix: 920, 1840, 3680 µg / mL - Vehicle / solvent:
- Name: Acetone, purity (GC) 99.5 %
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration:
short term treatment: 6 hours treatment 18 hours recovery
continous treatment: 24 hours
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: Solvent control: 2; others: 2
NUMBER OF CELLS EVALUATED: 100 metaphases
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- A cell having at least one structural chromosomal aberration was classified as an aberrant cell. Aberrant cells were counted up excluding cells having only gaps. The test substance was judged to have a potential to induce chromosomal aberration as follows. When both of incidence of structural aberrant cells and that of numerical aberrant cells are less than 5 %, the test substance is negative (-). When either of the incidences is 5 % or more and less than 10 %, the test substance is inconclusive ( ±). When either of the incidences is 10% or more, the test substance is positive ( + ).
- Statistics:
- Standard statistical methods have been applied for data processing.
- Key result
- Species / strain:
- mammalian cell line, other: CHL/IU
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- ADDITIONAL INFORMATION ON CYTOTOXICITY:
The test material did not inhibit cell growth more than 50 % in each treatment. In a cytotox screening assay, precipitation was observed at and above 100 µg/mL. - Conclusions:
- It was concluded that the test item did not have clastogenic potential in this CHL/IU cell line system. The test item was thus not clastogenic in this in vitro test system.
- Executive summary:
An in vitro chromosomal aberration study was conducted using the established cell line (CHL/IU) from the lungs of a Chinese hamster to determine the clastogenic potential of the test item. The test performed as short-term test (3 +18 hours) and as continous treatment test for 24 hours. This study was performed according to Japanese GLP and the methods applied are fully compliant with the Japanese Guideline for Mutagenicity Testing.
According to a preliminary test, concentrations selected for the cell growth inhibition test were 10, 20, 30, 100, 200, 500, 1000, 2000, and 3680 µg/mL for the short-term treatment without S9 mix (-S9 mix) and with S9 mix ( +S9 mix). The test substance did not inhibit cell growth more than 50% in any test substance treatment group. Precipitatoin was observed at and above a test material concentration of 100 µg/mL. From these results, concentrations selected for the chromosomal aberration test were 920, 1840, and 3680 µg/mL for the short-term treatment. The incidences of cells with structural and numerical aberrant chromosomes were less than 5% in each test substance treatment group. Therefore, the judgement in the short-term treatment was negative, and the test in the continuous treatment was conducted. According to a preliminary test, concentrations selected for the cell growth inhibition test were 10, 20, 30, 100, 200, 500, 1000, 2000, and 3680 µg/mL for the continuous treatment. The test substance did not inhibit cell growth more than 50 % in any test substance treatment group. Precipitatoin was observed at and above a test material concentration of 100 µg/mL. From this result, concentrations selected for the chromosomal aberration test were 920, 1840, and 3680 µg/mL for the continuous treatment. The incidences of cells with structural and numerical aberrant chromosomes were less than 5% in each test substance treatment group.
It was concluded that the test item did not have clastogenic potential in this CHL/IU cell line system. Thus, the test item was not clastogenic in this in vitro test system.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jun 16 - Dec 10, 1998
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- The methodology, originally complying with the ICH guidelines, OECD Test Guideline 476 and Annex V, EEC Directive 79-831, was modified in this study in order to screen a large number of test materials. In brief, the main modification is the use of fewer concentrations of the test material, use of only single cultures per concentration and a simplified data reporting. No quality assurance inspection according to GLP guidelines has been performed. Due to these modifications, this report does not fulfill all the requirements for the registration of pharmaceuticals or chemicals.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- yes
- Remarks:
- fewer concentrations, single cultures, no GLP
- Principles of method if other than guideline:
- None
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Specific details on test material used for the study:
- Batch: E98751641
Indication: liquid crystal
Solvent: acetone - Target gene:
- TK gene
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- Growth media
Three media, supplementing RPMI 1640-medium with Glutamax 1 with different serum concentrations were used:
Exposure medium:
RPMI- 5 (RPM 1640 with 5% heat inactivated horse serum)
470 mL RPMI 1640
25 mL horse serum (heat-inactivated horse serum)
5 mL penicillin/streptomycin
Culture medium:
RPMI-10 (RPMI 1640 with 10% heat-inactivated horse serum)
445 mL RPMI 1640
50 mL horse serum (heat-inactivated horse serum)
5 mL penicillin/streptomycin
Survivor- and selection medium:
RPMI-20 (RPMI 1640 with 20% heat-inactivated horse serum)
395 mL RPMI 1640
100 mL horse serum (heat-inactivated horse serum)
5 mL penicillin/streptomycin - Metabolic activation:
- with and without
- Metabolic activation system:
- 10% rat liver homogenate (S9 mix) with standard co-factors
- Test concentrations with justification for top dose:
- in a range finding experiment, precipitation of the test material in the cell culture medium was macroscopically visible at the concentrations >/= 281 μg/mL. based on these findings the following
concentrations were selected for the first series in the main study in the presence and absence of S9 mix:
28.1, 88.9 and 281 μg test material/mL medium. - Vehicle / solvent:
- Acetone
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- other: 4-nitroquinoline N-oxide
- Details on test system and experimental conditions:
- see below
- Evaluation criteria:
- see below
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- It is concluded that the test material is non-mutagenic in this test system under conditions where the positive controls exerted potent mutagenic effects.
Referenceopen allclose all
See attachment
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the available data, the test item is not considered to be classified as mutagenic according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
